ZTS

Zoetis
NYSE

Real-time Quotes | Nasdaq Last Sale

114.30
-2.38
-2.04%
Opening 10:29 03/31 EDT
OPEN
115.34
PREV CLOSE
116.68
HIGH
116.23
LOW
113.90
VOLUME
513.76K
TURNOVER
--
52 WEEK HIGH
146.26
52 WEEK LOW
90.14
MARKET CAP
54.28B
P/E (TTM)
36.58
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ZTS and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 18 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average ZTS stock price target is 142.25 with a high estimate of 162.00 and a low estimate of 112.00.

EPS

ZTS News

More
  • Why These 7 Pharma Stocks Are Outplaying 90% Of The Stock Market
  • Investor's Business Daily · 2h ago
  • Cramer's lightning round: 'You do want to buy defense stocks right here'
  • CNBC.com · 14h ago
  • Cramer's lightning round: 'I like Lockheed Martin very much'
  • CNBC.com · 3d ago
  • IBD Stock Of The Day: How Fido's Drugmaker Is Shielded From Covid Volatility
  • Investor's Business Daily · 3d ago

Industry

Pharmaceuticals
-0.24%
Pharmaceuticals & Medical Research
-0.28%

Hot Stocks

Symbol
Price
%Change

About ZTS

Zoetis Inc. is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals. The Company's segments include the United States and International. Within each of these operating segments, it offers a product portfolio for both livestock and companion animal customers. Its livestock products include Ceftiofur injectable line, Draxxin, Spectramast, Bovi-Shield line, Rispoval line, Suvaxyn/Fostera, Embrex devices and Lutalyse. Its companion animal products include Clavamox/Synulox, Convenia, ProHeart, Revolution/Stronghold, Apoquel, Cerenia and Rimadyl.
More

Webull offers kinds of Zoetis Inc stock information, including NYSE:ZTS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ZTS stock news, and many more online research tools to help you make informed decisions.